Soleus Capital Master Fund, L.P.

13F Holdings History for UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

Symbol: URGN on Nasdaq
Investment type: Equity / Ordinary Shares, par value NIS 0.01 per share
Latest Disclosed Ownership: 2.19M shares
Security Ownership: 4.7%

Soleus Capital Master Fund, L.P. ownership in UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN)

2025-08-05 - Soleus Capital Master Fund, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2.19M shares of UroGen Pharma Ltd. Ordinary Shares, par value NIS 0.01 per share (URGN). This represents 4.7% percent ownership of the company. In their previous filing dated 2025-06-16, Soleus Capital Master Fund, L.P. had reported owning 2.33M shares, indicating a decrease of -6.02% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Soleus Capital Master Fund, L.P.	4.7%	-6%	$22.2M	2.19M	-140,000	-6.02%	$10.14	13G/A	6/30/2025	5 Aug 2025 17:00:03
Soleus Capital Master Fund, L.P.	5%		$23.6M	2.33M			$10.14	13G	6/13/2025	16 Jun 2025 17:00:58